0001209191-23-054884.txt : 20231109 0001209191-23-054884.hdr.sgml : 20231109 20231109173026 ACCESSION NUMBER: 0001209191-23-054884 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231102 FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ghai Jyotsna CENTRAL INDEX KEY: 0001999779 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40443 FILM NUMBER: 231393951 MAIL ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Singular Genomics Systems, Inc. CENTRAL INDEX KEY: 0001850906 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 812948451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-7830 MAIL ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-11-02 0 0001850906 Singular Genomics Systems, Inc. OMIC 0001999779 Ghai Jyotsna 3010 SCIENCE PARK ROAD SAN DIEGO CA 92121 0 1 0 0 Chief Operating Officer Common Stock 3000 D Employee Stock Option (Right to Buy) 0.36 2033-10-01 Common Stock 400000 D Restricted Stock Unit Common Stock 200000 D 25% of the the option shares vest and become exercisable on October 2, 2024, the remainder of the option shares vest in 36 equal monthly installments thereafter, beginning on November 2, 2024. 25% of the Restricted Stock Units vest on October 2, 2024, the remainder of the Restricted Stock Units vest in 12 equal quarterly installments thereafter, beginning on January 2, 2025. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock. Exhibit 24 - Power of Attorney /s/ Dalen Meeter, Attorney-in-Fact 2023-11-09 EX-24 2 attachment1.htm EX-24 DOCUMENT
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, the undersigned hereby constitutes and appoints each
of Dalen Meeter and Eric Stier, signing singly, and with full power of
substitution, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned a Form ID Application, if
required, and submit the same to the United States Securities and Exchange
Commission;
(2) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of Singular Genomics Systems, Inc. (the "Company")
or as a
holder of 10 percent or more of the Company's securities, Forms 3, 4 and 5, and
any amendments thereto, in accordance with Section 16 of the Securities Exchange
Act of 1934, as amended,
and the rules thereunder and, if necessary, such forms or similar reports
required by state or foreign regulators in jurisdictions in which the Company
operates;
(3) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute any such Form 3, 4 or 5 or
similar form or
report required by state or foreign regulators, and any amendments thereto, and
file such form or report with the United States Securities and Exchange
Commission and any stock exchange or
similar authority or appropriate state or foreign regulator; and
(3) take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of
or legally required to be done by the undersigned, it being understood that the
documents executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be
in such form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in their discretion on information provided to such
attorney-in-fact without independent
verification of such information;
(2) any documents prepared and or executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney will be in such form and will
contain such
information and disclosure as such attorney-in-fact, in his or her discretion,
deems necessary or desirable;
(3) neither the Company nor such attorney-in-fact assumes
(i) any liability for the undersigned's responsibility to comply with the
requirement of the Exchange Act,
(ii) any liability of the undersigned for any failure to comply with such
requirements,or
(iii) any obligation or liability of the undersigned for profit disgorgement
under Section 16(b) of the Exchange Act; and
(4) this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under the Exchange Act,
including
without limitation the reporting requirements under Section 16 of the Exchange
Act. The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents
and purposes as the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and confirming all
that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934, as amended, and the rules
thereunder.
This Power of Attorney may be filed with the SEC as a confirming statement of
the authority granted herein.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of
and transactions in securities issued by the Company, unless earlier revoked by
the undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this second day of November, 2023.
/s/ Jyotsna Ghai
Signature
Jyotsna Ghai
Print Name